These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 352384)

  • 21. The effect of trimipramine (Surmontil) on symptoms and healing of peptic ulcer. A double blind study.
    Wetterhus S; Aubert E; Berg CE; Bjerkeset T; Halvorsen L; Hovdenak N; Myren J; Roland M; Sigstad H; Guldahl M
    Scand J Gastroenterol Suppl; 1977; 43():33-8. PubMed ID: 323960
    [No Abstract]   [Full Text] [Related]  

  • 22. The pharmacology of tri-potassium di-citrato bismuthate (TDB).
    Wilson TR
    Postgrad Med J; 1975; 51(5 Suppl):18-21. PubMed ID: 781652
    [No Abstract]   [Full Text] [Related]  

  • 23. An endoscopic evaluation of gastric ulcer treated with a mixture containing bismuth ammonium citrate.
    Lanza FL
    Curr Ther Res Clin Exp; 1970 Dec; 12(12):779-88. PubMed ID: 4994682
    [No Abstract]   [Full Text] [Related]  

  • 24. A double-blind short-term clinical trial of furazolidone on peptic ulcers.
    Zheng ZT; Wang ZY; Chu YX; Li YN; Li QF; Lin SR; Xu ZM
    Chin Med J (Engl); 1985 Aug; 98(8):616-7. PubMed ID: 3937692
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical evaluation of De-Nol].
    Tomecki R; Habior A; Medrzejewski W
    Pol Tyg Lek; 1984 Sep; 39(37):1247-8. PubMed ID: 6390386
    [No Abstract]   [Full Text] [Related]  

  • 26. Caved-S and Ulcedal for peptic ulcer.
    Drug Ther Bull; 1973 Feb; 11(3):10-2. PubMed ID: 4571693
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevention of gastric mucosal lesions in rats by tri-potassium di-citrato bismuthate.
    Malandrino S; Campagnoli G; Borsa M; Guidoboni R; Tonon GC
    Arzneimittelforschung; 1984; 34(1):30-1. PubMed ID: 6367754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colloidal bismuth subcitrate tablets and placebo in chronic duodenal ulceration: a double-blind, randomised trial.
    Wilson P; Alp MH
    Med J Aust; 1982 Mar; 1(5):222-3. PubMed ID: 7045603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
    Tefera S; Berstad A; Bang CJ; Nysaeter G; Hatlebakk JG; Olafsson S; Nesje LB; Hausken T; Berstad K; Hundal O
    Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of gastroduodenal ulcer with plasmutan].
    Berard E; Gallavardin M
    Med Chir Dig; 1975; 4(1):57-60. PubMed ID: 1160427
    [No Abstract]   [Full Text] [Related]  

  • 31. Likelihood of relapse of duodenal ulcer after initial treatment with cimetidine or colloidal bismuth subcitrate.
    Miller JP; Hollanders D; Ravenscroft MM; Tweedle DE; Martin DF
    Scand J Gastroenterol Suppl; 1982; 80():39-42. PubMed ID: 6761851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of patients with peptic ulcer].
    Sakharchuk II; Onishuk VF
    Vrach Delo; 1968 Sep; 9():19-22. PubMed ID: 5740297
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical, radiological and endoscopic evaluation of the use of plasmutan in gastro-intestinal ulcerous diseases].
    Bergeron P; Gorce D; Tournier C; Tournut B
    Med Chir Dig; 1975; 4(4):264-5. PubMed ID: 1207205
    [No Abstract]   [Full Text] [Related]  

  • 34. Double-blind controlled trial with colloidal bismuth subcitrate in the treatment of symptomatic duodenal ulcers with special references to blood and urine bismuth levels.
    Dekker W; Reisma K
    Ann Clin Res; 1979 Jun; 11(3):94-7. PubMed ID: 386913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of tri-potassium di-citrato bismuthate (TDB) with ranitidine in healing and relapse of gastric ulcer.
    Cipollini F; Altilia F
    Br J Clin Pract; 1987 Apr; 41(4):707-9. PubMed ID: 3689651
    [No Abstract]   [Full Text] [Related]  

  • 36. Tripotassium dicitrato-bismuthate tablets v liquid in the treatment of duodenal ulcers.
    Lane M; Lee S; Tasman-Jones C; Nicholson G
    N Z Med J; 1985 Mar; 98(775):191-2. PubMed ID: 3885084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Present and future treatment of peptic ulcer and potential role of DE-NOL.
    Scand J Gastroenterol Suppl; 1982; 80():49-57. PubMed ID: 6761852
    [No Abstract]   [Full Text] [Related]  

  • 38. Short- and long-term treatment with cimetidine in peptic ulcer disease and the pharmacokinetics of cimetidine.
    Bodemar G; Norlander B; Walan A; Larsson R
    Scand J Gastroenterol Suppl; 1979; 55():96-106. PubMed ID: 395636
    [No Abstract]   [Full Text] [Related]  

  • 39. [Diagnosis and therapy of peptic ulcer. Clinical report with double-blind study].
    Bouzo H
    Med Welt; 1979 Jun; 30(25):979-84. PubMed ID: 379497
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of trimipramine on the healing of peptic ulcer. A double-blind study. Multicentre investigation-G.P.
    Nitter L; Haraldsson A; Holck P; Hoy C; Munthe-Kaas J; Myrhol K; Paulsen W
    Scand J Gastroenterol Suppl; 1977; 43():39-41. PubMed ID: 323961
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.